For Americans navigating the pharmacy counter, the price of a prescription is often just the beginning of the story. Behind ...

The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend ...

Trump is correct. Too many drug prices are too high. How pharmacy benefit managers help inflate the prices of drugs in ...

Hi, it’s Dong Cao and Manuel Baigorri in Hong Kong, looking at how some big-name international brands are reassessing their approach to business in China. Also today, Eli Lilly’s latest move to build ...

Some reasons for the tariffs include countering trade deficits to boosting domestic industries and pressuring foreign competitors.

Eli Lilly & Co. aims to offer a one-and-done heart-disease medicine by paying up to $1.3 billion for Verve Therapeutics Inc., the maker of a new gene-editing treatment, Lilly said on Tuesday.

Retail sales fell sharply in May as consumers pulled back after a sharp increase in spending in March to get ahead of ...

Drugmakers want more clarity from the Trump administration on the potential pharmaceutical tariffs, which some companies warn ...

Eli Lilly has agreed to acquire Verve Therapeutics for up to $1.3 billion in a deal designed to bolster the buyer’s cardiovascular treatment pipeline with Verve’s gene editing therapies, led by ...

SAINSBURY’S has hiked the price of its lunchtime meal deal by 20p. The popular midday lunch bundle has gone from £3.75 to ...

In March, the Food and Drug Administration approved Vykat XR, an extended-release version of the existing drug diazoxide choline, which eases the relentless hunger and may offer insights into the ...